|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/403 | |
| A61K 31/155 | |||
| A61K 9/32 | |||
| A61K 9/36 | |||
| A61K 9/34 | |||
| A61K 47/12 | |||
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/14 | |||
| A61K 45/06 | |||
| A61K 9/24 | |||
| A61K 31/4985 | |||
| A61K 31/70 |
| (11) | Number of the document | 2611442 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11758019.1 |
| Date of filing the European patent application | 2011-09-01 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/050212 |
| Date | 2011-09-01 |
| (87) | Number | WO 2012/031124 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 379970 P | 2010-09-03 | US |
| (72) |
NARANG, Ajit S., US
RAO, Venkatramana, M., US
DESAI, Divyakant, S., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
AstraZeneca UK Limited, 15 Stanhope Gate, London W1K 1LN, GB |
| (54) | DRUG FORMULATIONS USING WATER SOLUBLE ANTIOXIDANTS |
| DRUG FORMULATIONS USING WATER SOLUBLE ANTIOXIDANTS |